FDA supports expanded claims for Xpert Carba-R test for "superbugs"
Cepheid announced that it has received clearance from the FDA for expanded claims for Xpert® Carba-R, the first FDA-cleared test for detection of carbapenem resistance genes of multidrug resistant 'superbugs'. June 30, 2016